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Abstract
Background: Thedown-regulation of the major histocompatibilitycomplex class I (MHC-I) from thesurfaceof infected cellsby
the Nefproteinsofprimateimmunodeficiencyviruseslikelycontributestopathogenesisbyprovidingevasionofcell-mediated
immunity. HIV-1 Nef-induced down-regulation involves endosomal trafficking and a cooperative interaction between the
cytoplasmic domain (CD) of MHC-I, Nef, and the clathrin adaptor protein complex-1 (AP-1). The CD of MHC-I contains a key
tyrosine within the sequence YSQA that is required for down-regulation by Nef, but this sequence does not conform to the
canonical AP-binding tyrosine-based motif Yxxw, which mediates binding to the medium (m) subunits of AP complexes. We
previously proposed that Nef allows the MHC-I CD to bind the m subunit of AP-1 (m1) as if it contained a Yxxwmotif.
Methods and Findings: Here, we show that a direct interaction between the MHC-I CD/Nef and m1 plays a primary role in the
down-regulation of MHC-I: GST pulldown assays using recombinant proteins indicated that most of the MHC-I CD and Nef
residues that are required for the down-regulation in human cells contribute to direct interactions with a truncated version of
m1. Specifically, the tyrosine residue of the YSQA sequence in the MHC-I CD as well as Nef residues E62-65 and P78 each
contributed to the interaction between MHC-I CD/Nef and m1 in vitro, whereas Nef M20 had little to no role. Conversely,
residues F172/D174 and V392/L395 of the binding pocket on m1 for Yxxw motifs were required for a robust interaction.
Conclusions: ThesedataindicatethattheMHC-Icytoplasmicdomain,Nef,andtheC-terminal twothirdsofthemsubunit of AP-1
are sufficient toconstitute a biologically relevant interaction. The data alsorevealanunexpected role for a hydrophobic pocket in
m1 for interaction with MHC-I CD/Nef.
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Introduction
Human immunodeficiency virus type 1 (HIV-1) Nef is a 27 kDa
protein with no known enzymatic activity that appears to function
by mediating protein interactions. Nef contributes to high levels of
replication and the pathogenesis of primate lentiviruses such as
HIV-1 and Simian Immunodeficiency Virus. Nef is expressed in
abundance early during the viral replication cycle, and it down-
regulates major histocompatibility complex class I (MHC-I)
glycoproteins from the surface of infected cells. Nef has several
functions in addition to the down-regulation of MHC-I molecules
[1], such as the removal of CD4 from the surface of infected cells
[2], [3]. The Nef-mediated down-regulation of MHC-I and CD4
is dependent on specific sequences in the cytoplasmic domains of
these target proteins [4], [5]. In the case of MHC-I, Nef induces
not only internalization from the plasma membrane but also the
retention and degradation of MHC-I within the endo-lysosomal
system [6]. Nef also affects signaling through the T-cell receptor
CD3 in T-lymphocytes [7]. To perform these functions, Nef
associates with the plasma membrane and various endosomal
membranes via N-terminal myristoylation [8].
Membrane trafficking within the endosomal system is mediated
in part by vesicles coated with adaptor protein (AP) complexes.
The AP family consists of four members: adaptor protein complex-
1 (AP-1), adaptor protein complex-2 (AP-2), adaptor protein
complex-3 (AP-3), and adaptor protein complex-4 (AP-4). AP-1
and AP-2 (as well as AP-3 and AP-4) are heterotetramers. AP-1
contains the four subunits c, b1, m1, s1, whereas AP-2 contains a,
b2, m2, s2. These complexes localize to different membranes: AP-
1 is found on the membranes of the trans-Golgi network (TGN)
and endosomes, whereas AP-2 is found on the plasma membrane
[9]. The AP complexes recruit scaffolding proteins, such as
clathrin, as well as cargo proteins, including transmembrane
receptors and proteins that are resident throughout the endosomal
system.
AP-1 is a key cellular protein complex through which Nef mediates
the down-regulation of MHC-I [10]. Two distinct binding sites are
present on the AP-1 complex for target proteins: a site on the ‘‘hemi-
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based signalswhichconform to thesequence E/DxxxLw,a n dasi t eo n
the m1 subunit that binds to tyrosine-based signals which conform to
t h es e q u e n c eY x x w,w h e r ew represents a bulky hydrophobic residue
[11], [12]. The molecular basis for the binding of tyrosine-based and
dileucine-based motifs to AP complexes has been explained by X-ray
crystal structures [11], [12]. The crystal structure of the AP-2 m
subunit in complex with the peptide FYRALM reveals a ‘‘two prong
in socket’’ mechanism, in which one prong is the tyrosine residue of
the Yxxw sequence and the other prong is the hydrophobic residue at
the Y+3 position [11]. Recently, the crystal structure of the AP-2
complex with a peptide from CD4 containing a dileucine-based motif
revealed the basis for this interaction [12]. Biochemical analyses
further revealed a cooperative interaction between the cytoplasmic
domain of CD4, Nef, and the s2/a hemicomplex [13].
MHC-I, Nef and AP-1 appear to participate in a cooperative
interaction in which the MHC-I molecule and Nef together form a
novel ligand for AP-1 [14]. The molecular basis of this interaction is
poorly understood: the minimal components are not defined, and its
structural basis is unknown. Notably, the cytoplasmicdomain (CD) of
MHC-I contains a key tyrosine within the sequence YSQA that is
required for down-regulation by Nef. However, this sequence does
not conform to the canonical AP-binding tyrosine-based motif Yxxw.
To identify the minimal components sufficient for the interaction
between the MHC-I CD, Nef, and AP-1, the relevant proteins were
expressed recombinantly in E. coli, purified, and used for GST pull
down assays. In our experimental design, we used a chimeric protein
in which full-length Nef was fused to the C-terminus of the
cytoplasmic domain of MHC-I (MHC-I CD-Nef). We also used
two N-terminal truncation proteins of m1: m121 (residues 121–423)
and m158 (residues 158–423). We used truncated forms of m1i no u r
experiments, becauseof their better expression and solubility than the
full length m1 (residues 1–423). GST pull down assays demonstrated
the formation of a complex between MHC-I CD-Nef and m121 or
m158. Furthermore, the tyrosine within the MHC-I cytoplasmic
sequence YSQA and key residues within Nef that are important for
the down-regulation of MHC-I were required for this interaction.
Finally, residues F172, D174, V392 and L395, which line the tyrosine
motif-binding pocket in m1, were also required. These data indicate
that a direct interaction with m1 explains most of the previously
defined genetic determinants for the down-regulation of MHC-I by
Nef.The data also suggest that a currentlyunidentified residuewithin
either Nef or the MHC-I CD binds a hydrophobic pocket on m1.
Materials and Methods
Antibodies and Reagents
Ni-resin was purchased from Sigma (St. Louis, MO) and
GSTrap columns were purchased from GE Healthcare (Piscat-
away, NJ). Anti-His6-peroxidase mouse monoclonal antibody
(Clone His-2) for the detection of His6-tagged recombinant
proteins was purchased from Roche (USA Cat.
No.04905270001). Sheep anti-Nef antiserum was raised against
recombinant protein made in E.coli and provided by Dr. Celsa
Spina (UCSD). Mouse anti-b- actin antibody was purchased from
Sigma (St. Louis, MO). TOPO-TA cloning and Quickchange kit
for site directed mutagenesis were purchased from Invitrogen (San
Diego, USA) and Stratagene (San Diego, USA), respectively.
Flow Cytometry
CEM T cells (5610
6) were cotransfected according to the
manufacturer’s instructions, using an AMAXA Nucleofector (Lonza
Cologne AG) system at a concentration of 5610
6cells/ml and 11 mgo f
plasmid DNA. The plasmid DNA mix contained 1 mgo fp C G - G F P( a
transfection reporter gene) and 10 mg of one of the following pCIneo-
based CD8- fusion constructs: CD8-Nef, CD8-Nef LL/AA, CD8-CD-
Nef LL/AA, CD8-CD (Y320A)-Nef LL/AA and CD8-CD (in which
‘‘-CD’’ indicates the cytoplasmicd o m a i no fM H C - IA 2 )a n d‘ ‘ C D 8 ’ ’
indicates the luminal and transmembrane domains of CD8. Cells were
incubated at 37uC overnight, stained with mouse anti-human CD8
antibody conjugated with phycoerythrin (PE; BD Pharmigen), and
subsequently analyzed by two-color flow cytometry; a PE conjugated
isotype control antibody was used to set the gate for CD8-positive cells,
and untransfected cells were used to set the gate for GFP-positive cells.
Cloning, Expression and Purification of MHC-I CD and Nef
and Their Mutants
The sequence encoding HIV-1 Nef was previously fused to the
amino acid sequence of MHC-I cytoplasmic domain using PCR and
then inserted into the pGEX-4T1 vector, adding a GST tag at the N-
terminus end of the protein [14]. Similarly, an MHC-I CD-Nef LL/
AA mutant was previously cloned into the pGEX-4T vector, and the
mutations within this sequence are as described [14]. MHC-I CD-
only and Nef only GST-fusion proteins were cloned similarly [14].
These vectors were transformed into E. coli strain BL21 (DE3) pLysS.
The E. coli cells were grown overnight at 37uCi n1 0m lo fL Bm e d i u m
containing ampicillin (100 mg/ml). Cells were then inoculated into
500 ml of fresh LB medium containing ampicillin and agitated until
the culture density reached an OD600 of 0.6. The protein was over-
expressed at room temperature by the addition of isopropyl b-d-
thiogalactopyranoside (IPTG) to a final concentration of 1 mM. After
overnight induction, the bacterial cells were harvested by centrifuga-
tion at 5000 rpm for 10 minutes at 4uC. Wet cell pellets were
resuspended in 20 mM Tris HCl, pH 7.5 containing 150 mM NaCl
and lysed in buffer containing 50 mM Tris HCl, pH 8.0, 150 mM
NaCl, 5 mM EDTA, 10 mM MgCl2, 1 mM dithiothreitol (DTT),
protease inhibitor cocktail (Roche) and 1% (v/v) Triton X-100 for
3h r sa t4 uC. Crude cell lysates were centrifuged at 13,000 rpm for
1h ra t4 uC .T h es o l u b l ef r a c t i o n sw e r el o a d e do n t oG S T r a p1m lH P
columns pre-equilibrated with 50 mM Tris HCl, pH 8.0 and
150 mM NaCl; the columns were extensively washed with same
buffer and then eluted using 50 mM Tris pH, 8.0 containing 10 mM
reduced glutathione. The purity of the protein samples was analyzed
using 12% SDS-PAGE. Similarly, mutants encoding Y320A in the
MHC-I CD, and M20A, E62-65A, and P78A in Nef were cloned
previously [14],and expressed inE. coli strain BL 21 (DE3) pLysS cells.
All mutant proteins were purified using GSTrap columns.
Cloning, Expression and Purification of the AP-1 Medium
Subunit (m1) and Related Mutants
A plasmid encoding AP-1 medium subunit (m1) was obtained from
Dr. Juan Bonifacino (NIH). PCR primers with the restriction sites NdeI
and BamHI appended were used to clone three m1c o n s t r u c t s :m full-
length (1–423), m121 (121–423) and m158 (158–423). These
truncations were designed based on previous constructs expressing
variants of the highly related m2 subunit, which has been crystallized in
complex with a peptide containing a canonical YxxL motif [11].
These m1 sequences were ligated using the NdeIa n dBamHI sites into
the expression vector pET15b, which introduces a His6-tag at the N-
terminus. Proteins were expressed in E. coli BL21 (DE3) pLysS cells as
described above for the MHC-I CD-Nef GST-fusion constructs.
Soluble protein was obtained in the case of the m1-deletion constructs
m121 and m158. These two m1 proteins were then purified using Ni-
column affinity chromatography: supernatants after the lysis were
loaded onto a His trap Ni-column; the column was washed with a
buffer containing 20 mM Tris HCl pH, 7.5, 150 mM NaCl and
10 mM imidazole to remove unbound proteins; and then bound
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and 500 mM imidazole. The purity of the m1 containing fractions was
checked using 12 % SDS-PAGE. Similarly, we cloned and expressed
the m1 mutant F172A, D174S, V392A, and L395A. All m1 mutants
were made using the QuickChange kit (Stratagene) and confirmed by
DNA sequencing. The mutant proteins were expressed and purified as
described above for the m121 and m158 proteins.
Glutathione S-Transferase (GST) Pulldown Experiments
We performed binding studies in vitro using partially purified
recombinant proteins expressed in E. coli as described above.
These partially purified proteins were combined and incubated
overnight at 4uC. The next day, GST pulldowns were done by
loading the mixed proteins onto GSTrap 1 ml HP-columns.
Unbound proteins were removed by extensive washing using
50 mM Tris pH, 7.5 and 150 mM NaCl buffer. The bound
fractions were eluted using buffer containing 50 mM Tris pH, 8.0
and 10 mM reduced glutathione, then analyzed on SDS-PAGE
through Coomassie blue staining and/or Western blot.
Western Blot
Protein samples were suspended in gel loading buffer, boiled
and run on 12% SDS-PAGE. The proteins were transferred to a
polyvinylidene difluoride membrane (PVDF) membrane. Mem-
branes were blocked with 4% milk (w/v) in PBS-T buffer (0.02%
v/v Tween 20) for an hour. Anti-His6-peroxidase mouse
monoclonal antibody (1:4000) was added in 1% milk+PBS-T for
1.5 hr. In some experiments, anti-Nef antibody (1:1000) and anti-
bactin antibody (1:1000) were used, followed by appropriate
peroxidase conjugated secondary antibodies. After four washes
with PBS-T, proteins were detected using ECL reagent (GE
Healthcare). In some case the blots were subsequently stained with
Ponceau red to directly visualize the proteins.
Results and Discussion
Minimal Constituents of a Complex between the MHC-I
Cytoplasmic Domain, Nef, and m1 In Vitro
As described previously [14], the cytoplasmic domain (CD) of
MHC-I was fused to the N-terminus of HIV-1 Nef to compensate for
the weak interaction between them. This MHC-I CD-Nef chimera
was fused to GST (Figure 1) to create a protein for use in pulldown
assays with His6-tagged m1 proteins. For reference, NMR structures of
Nef residues 2–57 (PDB code: 1QA5) [15] and residues 56–206 (PDB
c o d e :2 N E F )[ 1 6 ]a r eu s e d .T h ed e s i g no ft h eM H C - IC D - N e fc h i m e r a
was initially based on studies showing that when the MHC-I a chain
was fused to Nef, it co-immunoprecipitated with the AP-1 complex in
T-cells [10]. However, the CD of MHC-I has no intrinsic binding
activity for the AP-1 complex or for its m subunit [14]. Therefore, for
our in vitro binding studies,we used GST, GST-MHC-I CD, and GST-
Nef as controls, which as predicted did not bind to the m1p r o t e i n s
efficiently (Figure 2A). In contrast, the GST-MHC-I CD-Nef and
Figure 1. Schematic representation of the GST-MHC-I CD-Nef
fusion protein. Key residues in MHC-I CD (Y320) and HIV1-Nef (M20,
E62-65, P78) used in mutational and binding studies are shown.
doi:10.1371/journal.pone.0008364.g001
Figure 2. Direct interaction between the MHC-I CD-Nef and m1:
partially purified recombinant proteins were used in GST pull-
d o w na s s a y sa n da n a l y z e do nS D S - P A G Eg e l sb ys t a i n i n gw i t h
Coomassie blue. (A A) From left to right: protein ladder, recombinant m121
and m158 proteins as markers, then six lanes of negative controls as
indicated. (B B) Specific binding between m1a n dM H C - IC D - N e f .R e c o m b i n a n t
proteins (‘‘Input’’) were run as markers. Right four lanes show binding of
m121 or m158 with either MHC-I CD-Nef or MHC-I CD-Nef LL/AA. Nef LL/AA
indicates alanine substitution of Nef residues L164 and L165.
doi:10.1371/journal.pone.0008364.g002
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proteins (Figure 2B) with efficiencies sufficient to enable detection of the
interaction directly by Coomassie staining of the protein gels.
In our GST pulldown assays, the binding between MHC-I CD-
Nef LL164/165AA and m1 was comparable to that between
MHC-I CD-Nef and m1 (Figure 2B). This was expected, because
although Nef contains a highly conserved dileucine-based adaptor-
protein binding motif (ExxxLL), this motif is required for
interaction with the c/s hemi-complex of AP-1, not for
interaction with m1 [17,18]. Nef can also bind directly to the m1
subunit of AP-1 [5], potentially in part through its acidic cluster
(E62-65), but this interaction is much weaker than that which
occurs when Nef is fused to the CD of MHC-I (Figure 2B and
[14]).
These results demonstrate a direct interaction between the m1
subunit and the fusion protein containing the sequences of the
MHC-I CD and Nef. Furthermore, the data recapitulated the
cooperative or synergistic nature of the interaction between the
MHC-I CD and Nef in binding m1 [14], since neither the CD nor
Nef alone had appreciable binding activity. The data also
indicated that the C-terminal two-thirds of m1 are sufficient for
this interaction. Very importantly, the use of purified recombinant
proteins expressed in E. coli cells suggests that the MHC-I CD and
Nef together are sufficient to bind directly to m1; no additional
components or mammalian cellular factors are necessary to
reconstitute binding in vitro.
A CD8-MHC-I CD-Nef Chimera Is Down-Regulated
Appropriately from the Surface of T Cells
To validate the above approach, which relies on an MHC-CD-
Nef chimeric protein sequence, we sought evidence that such a
chimera would be sorted appropriately within the endosomal
system of T cells. To test this, we constructed chimeras in which
the MHC-I CD-Nef sequence was fused to the C-terminus of the
lumenal and transmembrane domains of CD8. In these constructs,
the MHC-I CD-Nef sequence is the cytoplasmic domain of a
transmembrane protein that can be detected at the cell surface
with an antibody to CD8. We expressed these chimeric proteins in
T cells of the CEM line by transient transfection, and then
measured their expression at the cell surface using flow cytometry
[Figure 3 A, which shows the relative cell number vs. CD8 staining
intensity (phycoerythrin) for the mid to low intensity GFP-positive
(transfected) cells]. The mean phycoerythrin fluorescence intensi-
ties (CD8 surface levels) of the GFP-positive populations indicate
that the chimeric MHC-I CD-NefLL/AA sequence decreased the
expression at the cell surface by nearly 5-fold relative to the MHC-
I CD alone, whereas the NefLL/AA sequence alone decreased the
expression at the cell surface by only 3-fold. These date indicate
that in the context of the Nef LL164/165AA mutation, which does
not affect MHC-I down-regulation under native conditions [19],
the fusion of the MHC-I CD to Nef generates a chimeric protein
sequence that is recognized in T cells by the endosomal sorting
machinery. Furthermore, when we used the CD8-CD (Y320A)-
Nef LL/AA chimera, we observed an almost three-fold increase in
the expression at the cell surface relative to the CD8-CD-Nef LL/
AA chimera in which Y320 is intact. This result validated the role
of Y320 in the cytoplasmic tail of MHC-I in the down-regulation
of the MHC-I CD-Nef chimera from the cell surface and
substantiated its recognition by the endosomal sorting machinery.
The total cellular expression of the chimeric proteins containing
Nef was checked by western blot using an anti-Nef antibody
(Figure 3B). These data indicated that the differences in surface
expression detected by flow cytometry were not attributable to
differences in the steady state levels of protein expression or to
differences in transfection efficiency.
Key Residues in the MHC-I CD and in Nef Affect the Direct
Binding between the CD-Nef Chimera and m1 In Vitro
To validate genetically the biological relevance of the direct
binding in vitro described above, we tested residues in both the
MHC-I CD and Nef that are of known importance for the down-
regulation of MHC-I by Nef in human cells. These key residues in
both the MHC-I CD and Nef are shown by schematic
representation (Figure 1). The key residues that have been well
Figure 3. Surface expression in CEM T cells of CD8 chimeras containing the MHC-I CD, Nef, or the MHC-I CD-Nef chimeric sequence
as cytoplasmic domains was measured by flow cytometry. Cells were transfected to express GFP as well as the CD8-chimeras, and the cells
were gated for low and mid-intensity GFP expression. (A A) Relative cell number vs. relative fluorescence intensity of CD8 [phycoerythrin (PE)]. Mean
fluorescence intensities for CD8 (PE) are shown. The chimeric MHC-I CD-NefLL/AA sequence directs decreased expression at the cell surface relative to
the MHC-I CD alone or NefLL/AA alone. This activity of the MHC-I CD when fused to Nef depends on Y320. (B B) The total cellular expression of the
chimeric molecules containing Nef was evaluated by western blot. Equal volumes of the transfected cell suspensions were collected before the FACS
staining and lysed for western blot analysis using anti-Nef antibody. All chimeric molecules were expressed at a similar level. Actin was probed as a
loading control.
doi:10.1371/journal.pone.0008364.g003
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the acidic cluster E62-65, and P78 in Nef ([14] and references
therein). Although Y320 in the MHC-I CD is within the sequence
YSQA and does not conform to the tyrosine-based AP-binding
sequence motif (Yxxw), we and others have previously shown that
it likely binds the tyrosine-motif binding pocket of the m subunit of
AP-1 [14], [20]. Here, the mutation of Y320 to alanine
substantially affected the binding of the MHC-I CD-Nef chimera
to the m subunit of AP-1 in vitro (Figure 4), validating the proposed
role of this residue in binding directly to m1.
We also tested key residues in Nef for their roles in our direct
binding assay using recombinant proteins (Figure 4). The Nef
residues M20, E62-65 and P78 are of well-validated importance in
the down-regulation of MHC-I in human cells ([14] and references
therein). Interestingly, M20, which is present in a short a-helical
region near the membrane proximal N-terminus of Nef, had little
or no effect on the binding of the MHC-I CD-Nef chimera to m1
in our in vitro assay. This could be because the fusion of the N-
terminus of Nef to the CD of MHC-I ‘‘forces’’ the association of
the two protein sequences, and if Nef M20 is important for this
association under native conditions in vivo, then its role in the
chimera would be rendered moot. Alternatively, Nef M20 could
have a role distinct from participation in the ternary interaction of
MHC-I, Nef, and AP-1; for example, it could be involved in the
trafficking of Nef within the cell. In contrast to M20, Nef residues
E62-65 and P78 each contributed substantially to the interaction
with m1 (Figure 4).
As previously proposed [14], the acidic cluster E62-65 of Nef
could participate by binding to a basic patch on the m subunit;
m1 is predicted to be a highly basic protein and its C-terminal
two-thirds contains numerous positive charge clusters that
could interact electrostatically with the Nef acidic cluster.
Previous studies have suggested an alternative mechanism in
which Nef down-regulates MHC-I via an interaction of its
acidic cluster with PACS-1 (phosphofurin acidic cluster sorting
protein-1) [21]. Part of this mechanism would involve an
interaction in which PACS-1 connects Nef and AP-1 [21]. In
our in vitro binding assays, the use of recombinant proteins that
are expressed in E. coli obviates a role for cellular factors such as
PACS-1 in the binding between the MHC-I CD, Nef and m1. In
contrast to the Nef acidic cluster, which could potentially bind a
basic patch on m1, the substantial decrease in binding caused by
the P78A mutation has no obvious structural explanation at this
time.
Very importantly, mutation of these key residues (Y320 in the
CD of MHC-I; and M20, E62-65 and P78 in Nef) suggested that
the interactions between the recombinant MHC-I CD-Nef
chimera and the recombinant truncated m1 subunit observed in
vitro are highly specific. They recapitulate the binding observed
using intact AP-1 complexes obtained from human cytoplasm as
well as the binding observed using observed full-length m1
translated in vitro [14]. With the exception of Nef M20, all of the
mutant proteins with known defects in the down-regulation of
MHC-I in human cells had substantial defects in our in vitro
binding assays using purified recombinant proteins.
Residues of the m1 Subunit that Form the Binding Site for
Yxxw Motifs Are Required for Interaction with the MHC-
CD-Nef Chimera In Vitro
To further examine the basis of binding between the MHC-I
CD-Nef chimera and m1 and to test specifically the role of the
binding pocket on m1 for tyrosine-based motifs, two mutants of m1
were made: F172A/D174S and V392A/L395A. Residues F172
and D174 were mutated to disrupt the acceptor site for the
tyrosine, whereas V392 and L395 were mutated to disrupt the
acceptor site for the Y+3 residue, even though the Y+3 residue in
the YSQA MHC-I CD sequence was not expected to bind this
hydrophobic pocket. Surprisingly, both of these m1 mutants
showed decreased binding to the MHC-I CD-Nef chimera in
comparison to wild-type m1 (Figure 5). These m mutants confirm
Figure 4. GST pulldown of recombinant m1 in vitro using
chimeric proteins in which the MHC-I CD is fused to the N-
terminus of Nef and by MHC-I CD-Nef chimera mutants. Various
residues within the CD of MHC-I and Nef were mutated to alanine as
shown. (A A) A western blot of the pulldown was probed with anti-His
antibody to detect the recombinant m1( m121). Band quantitation using
Image J and setting the pulldown of m1 by GST-CD-Nef to 100% yielded
the following efficiencies for the constructs: GST-CD-NefLL/AA: 77%;
GST-CD(Y320A)-NefLL/AA: 16%; GST-CD-Nef M20A,LL/AA: 53%; GST-CD-
Nef E62-65A,LL/AA: 30%; GST-CD-Nef P78A,LL/AA: 19%. The results
shown are representative of three independent experiments. (B B) The
amounts of GST-proteins used for binding setup are shown by
Coomassie blue staining.
doi:10.1371/journal.pone.0008364.g004
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pocket of m1 in the interaction with MHC-I CD-Nef.
Comparison of the binding sites for tyrosine-based motifs within
the m subunits of AP-2 and AP-1 shows that the structure of the
peptide-binding site of m1 (PDB code: 1W63) [22] is very similar to
that of m2 (PDB code: 1BW8) [11]. In addition, the m subunit of
AP-1 shares ,40 % sequence identity to that of AP-2. Given the
importance of the residues F172/D174 and V392/L395 in
binding the MHC-I CD-Nef chimera and the crystal structure of
the peptide FYRALM with the m subunit of AP-2 [11], we predict
that residues F172, D174, V392, and V395 in m1 accommodate
the sequence YSQA in the MHC-I CD. Specifically, Y320 of the
MHC-I CD likely interacts with F172 and D174 of m1. In contrast,
we think it unlikely that A323 at the Y+3 position in the MHC-I
CD contributes directly to binding the hydrophobic pocket.
Instead, we favor the hypothesis that a currently unidentified
hydrophobic residue in the CD of MHC-I or in Nef makes a key
contact with the hydrophobic pocket on m1 formed by residues
V392 and L395. Structural evidence will be required to evaluate
these predictions.
Conclusion
A direct in vitro protein interaction assay using partially purified
recombinant proteins produced in E. coli demonstrated the
formation of a complex between an MHC-I CD-Nef chimeric
protein sequence and the C-terminal two-thirds of the m subunit of
AP-1. To validate the relevance of this binding, we tested residues
in both the MHC-I CD and Nef that are of known importance for
down-regulation in human cells. The tyrosine residue of the
YSQA sequence in the MHC-I CD as well as Nef residues E62-65
and P78 each contributed to the interaction, whereas Nef M20
had little to no role. Residues that line the binding pocket on m1
for Yxxw motifs, specifically F172 and D174 that form an acceptor
site for the tyrosine residue, and V392 and L395 that form an
acceptor site for the Y+3 hydrophobic residue, were also required
for this interaction. These data indicate that the MHC-I
cytoplasmic domain, Nef and the C-terminal two thirds of the m
subunit of AP-1 are sufficient to constitute a biologically relevant
interaction. The data also suggest that the hydrophobic pocket on
m1, which typically accommodates the Y+3 residue of Yxxw
motifs, recognizes the MHC-I CD/Nef complex by an as yet
undetermined mechanism.
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